AMN Healthcare Services (AMN)
(Real Time Quote from BATS)
$51.94 USD
+0.08 (0.15%)
Updated Aug 16, 2024 02:36 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Price, Consensus and EPS Surprise
AMN 51.94 +0.08(0.15%)
Will AMN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AMN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AMN
AMN Healthcare (AMN) Q2 Earnings Beat Estimates, Margins Down
Compared to Estimates, AMN Healthcare (AMN) Q2 Earnings: A Look at Key Metrics
AMN: What are Zacks experts saying now?
Zacks Private Portfolio Services
AMN Healthcare Services (AMN) Q2 Earnings and Revenues Top Estimates
Wall Street's Insights Into Key Metrics Ahead of AMN Healthcare (AMN) Q2 Earnings
AMN Healthcare (AMN) Unveils ShiftWise Flex Manager Hub App
Other News for AMN
IXJ: Healthcare Sector Dashboard For August
AMN Healthcare price target lowered by $9 at JMP Securities, here's why
Buy Rating on AMN Healthcare Services Amidst Mixed Performance and Positive Future Outlook
AMN Healthcare price target raised by $11 at BMO Capital, here's why
The 3 Best Healthcare Stocks to Buy in August 2024